http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100428470-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 2001-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100428470-B1 |
| titleOfInvention | AN ACYL-CoA: CHOLESTEROL ACYLTRANSFERASE INHIBITOR AND A THERAPEUTIC AGENT CONTAINING PHEOPHORBIDE A, PORPHYRIN-TYPE COMPOUND OR EXTRACTS OF PERSICARIA VULGARIS AS AN EFFECTIVE INGREDIENT FOR THE TREATMENT OF CARDIOVASCULAR DISEASE |
| abstract | The present invention relates to the use of a porphyrin compound (pheophorbide a) and a spring extract containing the same, which is a porphyrin-based compound represented by the following formula (1), and more specifically, a porphine-based compound fairpoid A And spring extracts specifically inhibit the activity of Acyl-CoA: Cholesterol Acyltransferase, which is useful as an agent for preventing and treating cardiovascular diseases such as hyperlipidemia and arteriosclerosis caused by hypercholesterolemia. Can be used. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101067196-B1 |
| priorityDate | 2001-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.